B

BioVeda China Fund

9 employees

BVCF is a private equity and venture capital firm.

Investor insights

Sectors invested in

Biotechnology11
Health Care8
Pharmaceutical7
Medical5
Health Diagnostics3
临床研究 and 生物制药2
Infectious diseases2
Biopharma2
Partnering1
NGS1
Genetics1
Precision Molecular Diagnostics1
CAR-T and Immuno therapy1
CLIA Lab1
Head and Neck Cancer Screening1
Whole Genome Sequencing1
Colorectal Cancer Mutation Detection1
Early Cancer Detection1
Liquid Biopsy1
SuperbDNA Technology1

Funding rounds participated in

$23M sweet spot round size

Most of their 18 investments are in rounds between $8.6M and $56M

Investor type

Private Equity Firm

Basic info

Industry

venture capital and private equity principals

Sectors

Financial Services
Finance
Venture Capital

Date founded

2005

Investments made

C

Cellenkos, Inc. raised $15M on November 4, 2021

Investors: BioVeda China Fund

O

Oculis S.A. raised $57M on May 4, 2021

Investors: Nan Fung Life Sciences, Tekla Capital Management, VI Partners AG, Earlybird Venture Capital, Wille Finance and BioVeda China Fund

D

Drug Farm Inc raised $56M on February 9, 2021

Investors: 浙江民营企业联合投资股份有限公司, WuXi AppTec and BioVeda China Fund

U

Undisclosed raised $104M on January 1, 2021

Investors: 深圳蓝海创业投资基金管理有限公司 and BioVeda China Fund

广

广东盛泽康华生物医药有限公司 raised undisclosed on September 23, 2020

Investors: BioVeda China Fund

-

- raised $325M on July 9, 2019

Investors: Athena Capital, Redmile Group, The Invus Group, Jebsen Capital and BioVeda China Fund

S

Stealth BioTherapeutics raised $100M on June 18, 2018

Investors: Kingdon Capital Management, Sagamore Investment Management and BioVeda China Fund

M

MicuRx Pharmaceuticals, Inc. raised $15M on December 7, 2017

Investors: 北京德联运通投资管理有限公司 and BioVeda China Fund

U

Undisclosed raised $50M on December 6, 2017

Investors: Tasly and BioVeda China Fund

祐和医药科技(北京)有限公司 raised $10M on July 1, 2017

Investors: BioVeda China Fund

FAQ